Kidney cancer trials in Spain

In Spain 36 Also abroad 485

36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Barcelona, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Sevilla, Valencia
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
Phase 1Taking people
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Where
Madrid
Age
18 years and over
People
130 worldwide
Run by
Sairopa B.V.
See details and how to joinNCT05856981
Phase 1Taking people
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Where
Barcelona
Age
18 years and over
People
362 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT05536141 · EU 2024-519142-70-00
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Pamplona, Pozuelo de Alarcón, Sabadell, Santander, Sevilla, Valencia, Vigo
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
No phaseNot yet taking people in Spain
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Where
Madrid
People
50 worldwide
Run by
Aristotle University Of Thessaloniki
See details and how to joinNCT07888322
Phase 1/2Taking people
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Where
Barcelona, Madrid
Age
18 years to 120 years
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Where
Madrid, Sevilla
Age
18 years and over
People
474 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00
Phase 1Taking people
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Where
Barcelona, Madrid, Sevilla
Age
18 years and over
People
300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00
Phase 1/2Taking people
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Where
Barcelona, Madrid, Málaga
Age
18 years and over
People
224 worldwide
Run by
Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00
Phase 1Taking people
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Where
Barcelona, Logroño, Madrid
Age
18 years and over
People
124 worldwide
Run by
Pliant Therapeutics, Inc.
See details and how to joinNCT06270706
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Barcelona, Madrid
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Badajoz, Barcelona, Madrid, Pamplona, Santander, Sevilla, Valencia
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 1/2Taking people
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Where
Lleida
Age
18 years and over
People
75 worldwide
Run by
Oncorena AB
See details and how to joinNCT05287945
Phase 1Not yet taking people in Spain
A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Madrid
Age
18 years and over
People
112 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295
Phase 3Taking people
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Where
Barakaldo, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Murcia, Ourense, Sabadell, Santander, Santiago De Compostela, Valencia, Valladolid, Vigo
Age
18 years and over
People
1,373 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-503317-29-00 · EU 2023-503317-29-00
Phase 1/2Taking people
Kidney cancer
Where
Lleida, Madrid
Age
18 years and over
People
105 worldwide
Run by
Oncorena AB
See details and how to join2023-505605-16-00 · EU 2023-505605-16-00
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
Age
18 years and over
People
2,285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Badalona, Barcelona, Madrid, Málaga, Pamplona
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1Taking people
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Barcelona, Córdoba
Age
18 years and over
People
281 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00
Phase 1Taking people
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Where
Barcelona, Madrid
Age
18 years and over
People
307 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00
Phase 3Taking people
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Where
Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Madrid, Santander, Valencia
Age
18 years and over
People
904 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00
Phase 2Not yet taking people in Spain
Genitourinary Tumors With Sacituzumab Tirumotecan
Where
Madrid
Age
18 years and over
People
100
Run by
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07716917 · EU 2026-526048-10-00
Phase 1Taking people
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Where
L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
248 worldwide
Run by
Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00
Phase 2Taking people
Radiopharmaceutical Treatment of Advanced Kidney Cancer
Where
Barcelona, Madrid
Age
18 years to 100 years
People
48 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06783348 · EU 2024-517899-38-00
Phase 2Not yet taking people in Spain
Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma
Where
Barcelona, Córdoba, L'Hospitalet de Llobregat, Lugo, Madrid, Ourense, Oviedo, Pamplona, Sabadell, Santander, Valencia, Zaragoza
Age
18 years and over
People
150
Run by
Vall d'Hebron Institute of Oncology
See details and how to joinNCT07593040 · EU 2024-519673-18-00